Alpha-MSH Peptides (Including KPV) as a New Class of Anti-Inflammatory and Immune Drugs
Alpha-MSH-derived peptides including KPV represent a new anti-inflammatory and immunomodulating drug class, working through NF-κB inhibition, Treg generation, and melanocortin receptor-independent pathways across multiple inflammatory conditions.
Quick Facts
What This Study Found
Alpha-MSH-derived peptides (KPV, ACTH fragments) constitute a new anti-inflammatory drug class operating through NF-κB inhibition, regulatory T-cell induction, and melanocortin receptor-dependent/independent pathways — applicable to IBD, arthritis, allergic, and neuroinflammatory diseases.
Key Numbers
How They Did This
review study on kpv, inflammation.
Why This Research Matters
Relevant for kpv, inflammation, immune-function.
The Bigger Picture
Advances peptide research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Alpha-MSH-derived peptides (KPV, ACTH fragments) constitute a new anti-inflammatory drug class operating through NF-κB inhibition, regulatory T-cell i
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2007.
- Original Title:
- alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.
- Published In:
- Annals of the rheumatic diseases, 66 Suppl 3(Suppl 3), iii52-5 (2007)
- Authors:
- Luger, Thomas A(3), Brzoska, Thomas(3)
- Database ID:
- RPEP-01263
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
Alpha-MSH Peptides (Including KPV) as a New Class of Anti-Inflammatory and Immune Drugs
What was found?
Alpha-MSH-derived peptides including KPV represent a new anti-inflammatory and immunomodulating drug class, working through NF-κB inhibition, Treg generation, and melanocortin receptor-independent pathways across multiple inflammatory conditions.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-01263APA
Luger, Thomas A; Brzoska, Thomas. (2007). alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.. Annals of the rheumatic diseases, 66 Suppl 3(Suppl 3), iii52-5.
MLA
Luger, Thomas A, et al. "alpha-MSH related peptides: a new class of anti-inflammatory and immunomodulating drugs.." Annals of the rheumatic diseases, 2007.
RethinkPeptides
RethinkPeptides Research Database. "alpha-MSH related peptides: a new class of anti-inflammatory..." RPEP-01263. Retrieved from https://rethinkpeptides.com/research/luger-2007-alphamsh-related-peptides-a
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.